Cutler Group’s Precision BioSciences DTIL Stock Holding History

Cutler Group’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-100	Closed	-$7K	–	4131
2019 Q4	$7K	Buy	+100	New	+$31.4K	﹤0.01%	2831

Other funds holding DTIL

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

WHAM

Windmill Hill Asset Management Waddesdon, United Kingdom $321M AUM 25.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cutler Group's DTIL Position: Q4 2020 in Review

Cutler Group sold out of Precision BioSciences (DTIL) in Q4 2020, closing a stake of 17 shares — an estimated $3K sold.

Cutler Group first reported a position in DTIL in Q4 2019 and held it in 3 quarters. The position peaked at $4K in Q2 2020. 118 funds tracked by Wall St. Rank hold DTIL as of Q4 2020.

Cutler Group reported no remaining Precision BioSciences position as of Q4 2020 after selling out during the quarter.
Cutler Group sold 17 Precision BioSciences shares in Q4 2020, an estimated $3K.
Cutler Group first reported a position in Precision BioSciences in Q4 2019 and held it in 3 quarters.
Cutler Group's Precision BioSciences position peaked at $4K in Q2 2020.
118 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2020.

Based on Cutler Group's 13F filing for Q4 2020, filed 21 Jan 2021.